STAT+: If Apple takes aim at fall-prevention, will the rest of the health system hear it?
Using troves of data from iPhone users, Apple thinks it’s cracked an elusive problem: Identifying…
Category: Medicine
Opinion: Patient advocacy groups and innovators must partner to advance new treatments
People living with debilitating conditions and life-threatening diseases are often put in the terrible position…
STAT+: The most intriguing health tech deals of the year (so far)
In the world of digital health, money is flying around like never before. All that…
STAT+: Is the Alzheimer’s Association really pushing Biogen to lower its new drug’s price — or is it lip service?
WASHINGTON — The Alzheimer’s Association stunned Washington last month when it urged Biogen to lower…
The 36 best books and podcasts on health and science to check out this summer
In this time of transition, we’re back with our annual list of health, medicine, and…
For people in sickle cell crisis, specialized infusion centers offer far better care than the ER, study finds
People with sickle cell disease who were experiencing acute pain crises received far better care…
Is Larq Bottle Worth It? We Answer 5 Biggest Questions About The Self-Cleaning Bottle
Reusable water bottles have become increasingly popular. It’s a convenient way to keep us hydrated…
STAT+: Regulators in many European countries fail to ensure clinical trial data are available
Amid ongoing concerns over clinical trial transparency, a new report finds “notable gaps” in the…
STAT+: Purdue wants to shower employees with nearly $35 million in different kinds of bonuses
As Purdue Pharma attempts to win a controversial reorganization plan in bankruptcy court, the drug…
STAT+: Supreme Court to take up hospitals’ challenge to Medicare drug pay cuts
WASHINGTON — In a win for safety-net hospitals, the Supreme Court decided to hear their…
.jpg)
STAT+: Pharmalittle: Glaxo rejects hedge fund’s demands; FTC approves resolutions to probe pharma repeat offenders
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Regeneron’s George Yancopoulos talks CRISPR, obesity drugs, and the next generation of Covid antibody cocktails
The discovery of a rare genetic mutation that seems to protect certain people from becoming…
Opinion: Outdated Medicare rules threaten older Americans’ access to home medical equipment
Pandemic-related breaks in global supply chains for drugs and essential medical supplies are affecting the…
Opinion: The health care workforce is understaffed for life after Covid-19
As the U.S. gradually unburies itself from the Covid-19 pandemic, some people have been sounding…
Scientists devise a battery-free pacemaker that can be absorbed by the body
Scientists have designed a temporary, battery-free pacemaker that can be broken down by the patient’s…
STAT+: Inside the ‘land grab’ for virtual-first care: how an unprecedented flurry of deals is shaping the new digital health landscape
Teladoc’s blockbuster merger with Livongo in 2020 would’ve been unthinkable just a few years ago….
.jpg)
Genomic Surveillance: What It Is And Why We Need More Of It To Track Coronavirus Variants And Help End The COVID-19 Pandemic
Sequencing the genetic code of virus samples taken from COVID-19 patients reveals how SARS-CoV-2 is…
One Change That Could Help Nursing Homes Recover From COVID-19 Fears And Become Safer Places For Aging Parents
Throughout the pandemic, nursing homes have been in the headlines as places with uncontrolled COVID-19…
Listen: A CRISPR milestone, Biogen’s FDA saga, & George Yancopoulos on biotech in 2021
How much can CRISPR really do? Has the FDA been totally honest? And is it…
7 Quick Ways To Relieve COVID Vaccine Arm Pain And Swelling
Are you experiencing arm pain and swelling as a COVID vaccine side effect? Here are…
STAT+: U.S. cancer drug prices were higher at launch than in three European countries — and just kept climbing
In the latest bid to compare drug costs, a new study finds that prices for…
Researchers raise concerns about using genetic risk scores to pick ‘healthier’ embryos
As more people turn to in vitro fertilization for help with conceiving, a host of…
STAT+: Nestle Health Science will split profits from Seres microbiome drug, if it’s approved
Seres Therapeutics has announced a new deal with its long-time partner, Nestle Health Science, to…
STAT+: Pharmalittle: Glaxo under more pressure from activist investor; WHO urges Gilead to lower price of black-fungus drug
Hello, everyone, and how are you today? A shiny sun and delightful breeze are enveloping…
STAT+: In a new role at health tech startup Maven, Neel Shah wants to make sure pregnant people aren’t ‘lost’
When celebrated Boston OB-GYN Neel Shah first learned of the chance to help build a…
Could editing the genomes of bats prevent future coronavirus pandemics? Two scientists think it’s worth a try
Amid the devastating Covid-19 pandemic, two researchers are proposing a drastic way to stop future…
Opinion: Something to celebrate: delivering vaccines to essential workers
Covid-19 vaccines are cause for celebration. Family members are reuniting, people are traveling and returning…
STAT+: The biotech scorecard for the third quarter: 12 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third…
STAT+: Washington’s antitrust push could limit Amazon, Google’s health care ambitions
WASHINGTON — Washington is abuzz with an ambitious new antitrust effort to rein in the…
The Ethical Questions Raised By COVID-19 Vaccines: 5 Essential Reads
The ethical debate isn’t just around those who refuse, or are hesitant, to be vaccinated….
Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug
WASHINGTON — Former health secretary Donna Shalala called for a federal investigation into the Food…
STAT+: Mallinckrodt cleared to sell a rare disease drug to a startup, but parents worried over ongoing access
A federal bankruptcy court judge has approved the sale of a rare disease drug to…
STAT+: Gene therapy to regenerate cardiac muscle after a heart attack passes a key test in pigs
By delivering a viral payload of gene silencers directly to the heart, scientists have developed…
STAT+: Pharmalittle: Most doctors disagree with FDA approval of the Alzheimer’s drug; women underrepresented in life sciences C-suites
Good morning, everyone, and how are you today? The heat continues to rise here on…
STAT+: Revised analysis nudges up cost-effective price for Biogen’s Alzheimer’s drug to $3,000 to $8,400 a year
The controversial new Alzheimer’s drug from Biogen (BIIB) would be cost-effective only if priced between…
Opinion: Listen: A sister on watching the mental health care system fail her brother
In this week’s episode of the “First Opinion Podcast,” Lizzy Feliciano talks about her brother,…
Opinion: Copay assistance should count as part of patients’ cost sharing for medications
The Biden administration has made health equity a priority and it has been a constant…
STAT+: Poll: Most neurologists and primary care doctors disagree with FDA’s approval of Alzheimer’s drug
A majority of U.S. physicians disagree with the decision by the Food and Drug Administration…
STAT+: The health tech tracker for the third quarter: 11 pivotal industry events to watch
The third quarter will answer crucial questions about the near-term future of digital health. Will…
12 lessons Covid-19 taught us about developing vaccines during a pandemic
The extraordinary drive to develop Covid-19 vaccines was like a moonshot — and like that fabled…
Demand is growing for continuous glucose monitoring for type 2 diabetes. Primary care doctors need to prepare
In the last year, Jai Smith has cycled through 13 primary care doctors. Ever since…
Did Sydney’s Lockdown Come Too Late? Here’s Why It’s Not That Simple
Analysing the outbreak aims to understand any additional cases that might have been prevented with…
South Africa’s Latest COVID-19 Lockdown Puts Spotlight Back On Vaccination Failures
South Africa is in the grip of another resurgence of COVID-19. Gauteng province, the country’s…
The WHO on ethical AI, Doximity’s ascent, & algorithms for IVF
You’re reading the web edition of Health Tech, STAT’s twice-weekly newsletter about how tech is…
Opinion: If Covid-19 vaccines can cause heart inflammation, caution should be warranted in those at risk
The remarkable development and rollout of Covid-19 vaccines will be hailed as a triumph of…
STAT+: STAT+ Conversations: A conversation about in vivo gene editing to treat rare disease
Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: How Biogen and FDA formed a back channel to push an Alzheimer’s drug; Sanofi to dive into mRNA vaccine development
Top of the morning to you. And a steamy one, it is. In fact, there…
Operation Warp Speed — now, the ‘CAG’— is here to stay
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: ‘This is not enough’: Walmart’s plan to sell another private label insulin is met with skepticism
Amid a national outcry over the cost of insulin, Walmart (WMT) plans to sell a…
Opinion: Public reporting: the first step in addressing the health care industry’s bloated carbon footprint
The health care industry focuses on healing. Yet its pursuit of that mission can cause…